|
|

| General
Information |

Common Name: |

Feverfew |
|
Latin
Name:
|
Tanacetum
parthenium |
|
Family:
|
Asteraceae |
| Other
Names: |
 |
Altamisa.
|
 |
Featherfoil.
|
 |
Febrifuge
plant
|
 |
Midsummer
daisy.
|
 |
Nosebleed.
|
 |
Wild
chamomilee.
|
 |
Santa
Maria.
|
|
| Indications
& Historical Uses |
|
Feverfew
was known to the ancient Egyptians and Greeks as a valuable herbal
remedy and was used as an anti-inflammatory agent. It was used
to treat headaches and for promoting menstrual flow.. Recent clinical
trials have substantiated its effectiveness as a remedy for migraine
headaches. It is used effectively for the prevention and treatment
of migraine headaches. It has also been suggested for inflammations,
nausea and vomiting, vertigo, arthritis, and as a digestive aid
.
|
| Contraindications
& Precautions |
|
Contraindications:
None known at present (See
Caution).
Precautions:
See Drug Interactions.
Adverse
Side Effects:
Feverfew is
usually well-tolerated and no serious side-effects have been reported.
Rarely, individuals allergic to the Compositae family of flowers
[e.g ragweed and chamomile ] may show hypersensitivity. 10% of
people taking fever few may develop mouth ulcers.
Drug
Interactions:
It has been shown that the concomitant use of NSAIDS or steroids
may reduce the effectiveness of Feverfew. Feverfew also has the
potential to decrease platelet aggregation and therefore patients
on anticoagulants should be closely monitored. See Caution .
|
| Dosage
Information |
|
How
Supplied:
|
As
capsules containing 500mg of parthenolide. |
|
Dosage:
|
One
capsule of extract containing 500 mg parthenolide per day. Feverfew
has to be taken for an entire month before beneficial effects are
noticeable in case of migraine prophylaxis. Also much higher doses
are required to abort an acute attack of migraine.[1-2 gm ]. |
| Pharmacology
|
|
The
most pharmacologically active ingredient is Parthenolide. Feverfew
contains a number of other not so active, bitter tasting sesquiterpene
lactones. Research studies have determined that parthenolide,
michefuscalide, and chrysanthenyl acetate inhibit the production
of prostaglandins. Though it does not directly inhibit cyclo-oxygenase
like ASA or NSAIDS, it does appear to inhibit the release of arachidonic
acid which reduces substrate for both prostaglandins and leukotriene
synthesis. Feverfew also inhibits degranulation in platelets and
leukocytes, and this in turn results in the decreased secretion
of serotonin and histamine.
Inhibition
of prostaglandins production results in reduction of inflammation,
decreased secretion of histamine, decreased activation of inflammatory
cells and a reduction of fever, hence the name. While the anti-
inflammatory effect is of some benefit, the major beneficial effect
is due to its effects on histamine and serotonin. It is postulated
that it is the inhibtion of serotonin and histamine release that
reduces the spasm of the cerebral blood vessels, thus preventing
and controlling migraine headaches.
In
addition to its anti-inflammatory activities, feverfew is also
known for relaxing the smooth muscles in the uterus and promoting
menstrual flow and for inhibiting platelet aggregation and excessive
blood clotting.
As
a bitter herb, feverfew has been used in stimulating digestion
and improving the function of the liver.
|
|
Active
Ingredients:
|
Principal
active ingredient is parthenolide - a sequestrene lactone. Other
sequesterpene lactones are chrysanthemonin, Chrysartemin A and
B and Santamarin. Other active substances are tannins, betafarnesene
and camphor. Standardized amount of active ingredient is 0.1 -
0.5 % parthenolide.
|
| Origin |
|
Feverfew
is a member of the daisy family, similar to the tansy and chrysanthemum.
It is native to Germany, Holland, U.K. and Israel. Feverfew is
a short , bushy perennial with daisylike yellow and white flowers
and closely resembles chamomile. The yellow-green leaves are used
medicinally.
|
| Processing |
|
Active
ingredient is extracted from the harvested leaves. The extract
is then concentrated to the guaranteed potency.
|
| Scientific
References |
 |
S. Foster: Feverfew, Tanacetum parthenium, Botanical series
No 310. American Botanical Council, Austin,Texas
(1991) p.p. 8.
|
 |
Weiner, M. (1990) Weiner's Herbal. Mill Valley, CA:
Quantum Books.
|
 |
Grieve,
M. (1978) A Modern Herbal. Middlesex, UK: Penguin
Books.
|
 |
Heptinstall, S. (1988) Feverfew-- An ancient remedy for
modern times? J. Royal Soc. Med. 81:373-374.
|
 |
Bohlmann, F. and Zdero, C. (1982) Sesquiterpene lactones
and other constituents from Tanacetum parthenum. Phytochemistry
21:2543
|
 |
Makheja, A. and Bailey, J. (1981) The active principle of
Feverfew. Lancet 2:1054.
|
 |
Jhnson,
E.S. et al. (1985) Efficacy of Feverfew as prophylactic
treatment of migraine. Brit. Med. J. 291:569.
|
 |
Murphy, J.J. et al. (1988) Randomised double-blind trial
of Feverfew in migraine prevention. The Lancet 2:189.
|
|
| Back
To Index |
|